Picture of Baudax Bio logo

BXRXQ — Baudax Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Baudax Bio Inc expected to post earnings of $5.79 a share - Earnings Preview

* Baudax Bio Inc  BXRX.OQ   BXRX.O  is expected to show a
fall in
quarterly revenue when it reports  results on May 2
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Baudax Bio Inc is
for
earnings of $5.79 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$24​, above​ its last closing price of $0.78. ​​​

This summary was machine generated April 28 at 11:55 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Baudax Bio

See all news